Noor Asyikin Suaidi

Ms. Noor Asyikin Suaidi

University of Malaya, Kuala Lumpur, Malaysia
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2022 in Toxics
Verified
Journal Article
Open access
PDF file
NSNoor Asyikin Suaidi
Noor Asyikin Suaidi
Mohammed Abdullah AlshawshMohammed Abdullah Alshawsh
Mohammed Abdullah Alshawsh
SHSee-Ziau Hoe
See-Ziau Hoe
MMMohd Helmy Mokhtar
Mohd Helmy Mokhtar
Siti Rosmani Md ZinSiti Rosmani Md Zin
Siti Rosmani Md Zin
Technical xylene is a compound of massive production that is used in applications such as petrochemical and healthcare laboratories. Exposure to xylene can cause acute and chronic effects in humans and animals. Currently available studies regarding xylene’s adverse effects with credible designs were dated almost twenty years ago. This systematic review summarizes the findings regarding the detrimental effects of technical xylene from human, animal, and in vitro studies. It recapitulated available studies with respect to the effects of xylene on the female reproductive system to stress the need for updating the current data and guidelines. Based on pre-specified criteria, 22 studies from journal databases exploring the toxic effects of xylene on menstruation, endocrine endpoints, fetal development, and reproductive functions were included for the review. It was found that related studies with a specific focus on the effects of technical xylene on the female reproductive system were insufficient. Therefore, further studies are necessary to update the existing data, thus improving the quality and reliability of risk assessment of exposure to xylene in pregnant women

23 September 2024 in Toxicology and Industrial Health
Verified
Journal Article
Closed access
NSNoor Asyikin Suaidi
Noor Asyikin Suaidi
MAMohammed Abdullah Alshawsh
Mohammed Abdullah Alshawsh
SHSee-Ziau Hoe
See-Ziau Hoe
MMMohd Helmy Mokhtar
Mohd Helmy Mokhtar
SZSiti Rosmani Md Zin
Siti Rosmani Md Zin
The potential maternal and foetal toxicity resulting from exposure to xylene at or below the allowable limit of 100 ppm during gestation is not thoroughly studied. The aim of this study was to investigate maternal and foetal outcomes following prenatal exposure to xylene during organogenesis. Pregnant Sprague Dawley (SD) rats were administered intraperitoneal (IP) corn oil (vehicle), 100, 500, and 1000 parts per million (ppm) of xylene from gestational day (GD) 6 until GD17. Clinical signs, maternal weight gain, and food consumption were recorded daily. A caesarean hysterectomy was performed on GD21 to assess the reproductive and foetal outcomes. Exposure to 1000 ppm of xylene caused a significant decrease in the maternal body weight and food consumption, and an increase in intrauterine foetal deaths. Foetal assessment revealed a significant decrease in foetal weight in both male and female foetuses of female rats treated with 500 and 1000 ppm. Male placental weight was significantly decreased in all xylene-treated groups, while 1000 ppm xylene significantly decreased female placental weight. Histologically, marked uterine inflammatory lesions, fibrosis of the liver and renal tissues, as well as increased placental glycogen content were observed. Immunohistochemistry revealed a significant increase in lipid peroxidation and apoptotic markers. Thus, the foeto-maternal toxicities of xylene have been shown to be mediated by a systemic inflammatory response that exacerbates intrauterine oxidative stress and impairs foeto-placental transfer, leading to an increase in foetal mortality.

Verified
Journal Article
Open access
PDF file
MKMwafaq Kmail
Mwafaq Kmail
NSNoor Asyikin Suaidi
Noor Asyikin Suaidi
Chin Jin HanChin Jin Han
Chin Jin Han
LLLee Wei Lim
Lee Wei Lim
Kah Hui WongKah Hui Wong
Kah Hui Wong
Spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease, is the most common autosomal dominant spinocerebellar ataxia and is characterized by progressive neurodegeneration for which no Food and Drug Administration (FDA)-approved therapeutics are currently available. Mitochondrial dysfunction has emerged as a central pathogenic mechanism in SCA3, making it a promising therapeutic target. This narrative review aims to evaluate the published evidence on the therapeutic potential of natural medicines and their active compounds targeting mitochondrial dysfunction in SCA3. This review summarizes published evidence on the therapeutic potential of natural medicines and their active compounds targeting mitochondrial dysfunction in SCA3 in preclinical studies. The reviewed studies suggest the therapeutic potential of Glycyrrhiza inflata, Codonopsis pilosula, Ginkgo biloba, Poria cocos, Pueraria lobata, Rehmannia glutinosa, Curcuma longa, Hericium erinaceus, Astragalus membranaceus, Hemerocallis citrina, caffeic acid, and resveratrol in targeting mitochondrial dysfunction in SCA3. These natural medicines were reported to regulate multiple mitochondrial-associated pathways, including oxidative stress, mitochondrial membrane potential, mitochondrial bioenergetics, mitochondrial dynamics, mitochondrial quality control, and mitochondria-mediated apoptosis, thereby improving neuronal survival and mitochondrial function in experimental SCA3 models. In conclusion, natural medicines targeting mitochondrial dysfunction represent promising preclinical candidates for further investigation in SCA3. However, further mechanistic investigations, well-designed clinical trials, and optimization of pharmacokinetic properties are required to facilitate their translation into clinical practice.